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252 Accuracy of simple methods to estimate body composition in
cystic ﬁbrosis patients
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Background: Fat free mass (FFM) depletion was reported in CF pts and is
associated with worse pulmonary function. These ﬁndings suggest that monitoring
of body composition (BC) should be introduced in clinical practice. However,
the accuracy of simple methods to predict BC, such as skinfold thickness (SFT)
measurements and bioimpedance (BIA), has been poorly investigated in CF.
Aims: To evaluate the accuracy of equations based on SFT and BIA parameters
for estimation of 2-compartment BC model (FFM&FM).
Methods: Dual energy X-ray absorptiometry (DXA), 50 kHz BIA (Akern 101) and
SFT measurements were performed on 138 CF pts (median age = 16 yrs, range =
8−47 yrs, 62 males). DXA was used as the criterion method for the estimation of
FFM and FM. The equations developed by Slaughter (pts <17 yrs) and by Durnin
(pts17 yrs) based on SFT and the equations provided by the manufacter of BIA de-
vice (Bodygram PRO 3.0) were used to estimate percentage of fat mass (%FM).
The difference between estimated and measured values by DEXA (bias), and the
limits of agreement (Bland–Altman 95% limits of agreement) (LA) were calculated
to compare accuracy of estimations.
Results: In pts aged <17 yrs Slaughter equation signiﬁcantly underestimated %FM
(p< 0.0001). Mean bias was −3.7% (−10.9, 3.4) using Slaughter equation and −0.2%
(−9.3, 8.9) using BIA. In pts aged 17 yrs, mean bias was −0.5% (−6.9, 5.9) using
Durnin equation and −1.0% (−9.1, 7.2) using BIA.
Conclusions: The estimation of BC by simple methods should be used with
caution in CF patients, due to wide intra-individual differences. Population speciﬁc
equations should be provided to make these methods of clinical usefulness.
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Objectives: Malnutrition in CF patients is associated with severe lung disease and
worse survival. Body mass index (BMI) is a well-known marker of nutritional status.
PA is the most established impedance parameter for the diagnosis of malnutrition
and clinical prognosis in different diseases; it documents the quality of soft tissue
mass. The aim of this study was to investigate which is the better indicator of
nutritional status in children with CF.
Methods: In a prospective study we evaluated BMI Z-score, PA Z-score, FEV1,
exercise capacity (EC; peak cycle exercise testing, Godfrey protocol) and daily
activity (DA, activity sensor “Sensewear armband” for 7 days) from all CF patients
(6 to 17 years) coming routinely in our CF centre.
Results: We analysed the following data (MW±SD) from 156 patients (78 males,
78 females), aged 11.3±3.4 years: BMI Z-score 0.5±0.9; PA Z-score 0.4±1.0,
FEV1 90±19.6%, EC 93.5±20.6% of norm, DA (daily time with high activ-
ity, >6METs): 45.3±48.3 minutes. While the PA correlates with BMI Z-score
(r = 0.186, p = 0.022) we found good correlations from BMI Z-score with FEV1
(r = 0.326, p< 0.001) and EC (r = 0.299, p< 0.001) and only a correlation between
PA and EC (r = 0.289, p = 0.001). No correlations were found between BMI Z-score
or PA and daily activity.
Conclusions: Our results conﬁrm the association between nutritional status and
lung disease in children with CF. Patients in better nutritional status demonstrate
higher EC. Increased activity doesn’t inﬂuence the body composition in our young
patients. It seems that measurement of PA from BIA isn’t a better indicator for
nutritional status and prognosis in CF children in good clinical status.
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Background: Optimising nutrition and lung function are core elements of treatment
in CF. Current practice recommends monitoring body mass index (BMI) as an
indicator of nutritional status. However, BMI does not recognise body composition
such as fat free mass (FFM). Research suggests a low FEV1 in combination with
a low FFM as a predictor of higher mortality rate in CF.
Aim: To map our CF population identifying subjects with hidden depleted FFM
using bioelectrical impedance (BIA).
Method: BIA was used at annual review in 117 adult CF patients. Age, gender,
BMI, FFM, calculated as FFM index (FFMI) was correlated with pancreatic status,
genotype, FEV1% predicted and methods of nutritional support. Data was compared
against published values for healthy age- and gender-matched population (n = 4463).
Low FFM was deﬁned as a FFMI <5th percentile of this control group.
Results: Of the 117 (69 male) patients with mean (range) age 28 (17−53) years
and mean±SD FEV1% predicted 66±24%, 103 were pancreatic insufﬁcient (PI),
11 received enteral feeding. 13 (10 male) had low FFMI, 12 of whom were PI and
7 had hidden loss of FFM (normal BMI and low FFMI). There was a signiﬁcant
correlation between FEV1% and low FFMI, hidden low FFMI and enteral feeding
(all p< 0.05). No signiﬁcant difference was seen when comparing low FFM with
genotype or pancreatic status.
Conclusion: BMI alone does not identify patients with hidden depleted fat free
mass, with more than half those patients with low FFMI not being identiﬁed using
BMI alone. BIA is a safe and practical tool and appears able to identify hidden low
FFM in CF patients allowing speciﬁc nutritional and exercise advice to be provided.
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Background: Patients with CF are at risk of muscle mass depletion as a con-
sequence of malnutrition, chronic inﬂammation and recurrent infection. Body
Mass Index (BMI) is routinely used to monitor nutritional status but gives no
information about body composition. Studies have highlighted that weight-based
indicators underestimate the prevalence of malnutrition in CF (McNaughton SA,
2000). Body composition measurements of fat and lean body mass using DEXA
are time consuming and costly. However, an alternative approach (validated in
other conditions) is to assess peripheral muscle function by testing hand grip
strength (HGS), which is rapid, easy to perform and reliable (Innes E, 1999). HGS
is not currently routinely measured in CF.
Patients and Methods: HGS, BMI and FEV1% predicted were measured in
139 sequential adult patients attending CF annual review. A dietitian measured
HGS using a Jamar digital dynamometer and a standardised protocol. Results
were compared to data for age and gender-matched controls (Klidjian AM et al.,
1982). Patients were divided into those with HGS 85% predicted and those with
HGS <85% predicted.
Results: Low HGS was associated with lower BMI and FEV1% predicted (Table 1).
Table 1
HGS
85% predicted
HGS
<85% predicted
P value
(unpaired
t test)
Male 30/57 (53%) 39/82 (48%)
Mean HGS (kg) 36.3 (SD ±10.1) 23.2 (SD ±6.8) 0.0001
Mean BMI (kg/m2) 23.2 (SD ±2.7) 21.3 (SD ±3.1) 0.0002
Mean FEV1 (% predicted) 74.5 (SD ±22.4) 55.0 (SD ±21.2) 0.0001
Conclusion: HGS is a new functional outcome measure in CF. Further research is
required to demonstrate its clinical utility in CF. Patients with HGS <85% normal
are likely to have lower BMI and FEV1% predicted.
